Mizuno Kanako, Inose Ryo, Matsui Yuna, Takata Mai, Yamasaki Daisuke, Kusama Yoshiki, Koizumi Ryuji, Ishikane Masahiro, Tanabe Masaki, Ohge Hiroki, Ohmagari Norio, Muraki Yuichi
Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Kyoto 607-8414, Japan.
Department of Infection Control and Prevention, Mie University Hospital, Tsu 514-8507, Japan.
Antibiotics (Basel). 2022 Jun 2;11(6):763. doi: 10.3390/antibiotics11060763.
The evaluation indexes of antimicrobial use (AMU) in sub-prefectural regions have not been established because these regional units are susceptible to the effects of population inflows and outflows. We defined the difference in AMU calculated each year as a new evaluation index and compared the AMU of secondary medical areas with those already reported for Japan and each prefecture. Patients/1000 inhabitants/day (PID) for oral antibiotics in 2013 and 2016 were calculated using the National Database of Health Insurance Claims and Specific Health Checkups. ΔPID was defined as the difference between the PIDs in 2013 and 2016. Differences in AMUs for Japan and prefectures that have already been published were also calculated, and the concordance rate with ΔPID in each secondary medical area was evaluated. Antibiotics and age groups with less than 50% concordance between secondary medical area and previously reported AMU changes were observed. This revealed that even at the secondary medical area level, which is more detailed than the prefectural level, the AMU changes were not consistent. Therefore, in order to appropriately promote measures against antimicrobial resistance, we suggest the necessity of not only surveying AMU at the national or prefectural levels but also examining sub-prefectural trends in AMU.
由于地区级单位容易受到人口流入和流出的影响,因此尚未建立地区级抗菌药物使用(AMU)的评估指标。我们将每年计算的AMU差异定义为一个新的评估指标,并将二级医疗区域的AMU与日本及各都道府县已报告的AMU进行比较。使用全国健康保险理赔和特定健康检查数据库计算了2013年和2016年口服抗生素的患者/1000居民/天(PID)。ΔPID定义为2013年和2016年PID之间的差异。还计算了日本和已公布的都道府县的AMU差异,并评估了每个二级医疗区域与ΔPID的一致性率。观察到二级医疗区域与先前报告的AMU变化之间一致性低于50%的抗生素和年龄组。这表明,即使在比都道府县级别更详细的二级医疗区域层面,AMU变化也不一致。因此,为了适当地推动抗菌药物耐药性应对措施,我们建议不仅有必要在国家或都道府县层面调查AMU,还需要研究地区级的AMU趋势。